Living with an imperfect cell wall: compensation of femAB inactivation in Staphylococcus aureus

Hübscher, Judith; Jansen, Andrea; Kotte, Oliver; Schäfer, Juliane; Majcherczyk, Paul A; Harris, Llinos G; Bierbaum, Gabriele; Heinemann, Matthias; Berger-Bachi, Brigitte
January 2007
BMC Genomics;2007, Vol. 8, p1
Academic Journal
Background: Synthesis of the Staphylococcus aureus peptidoglycan pentaglycine interpeptide bridge is catalyzed by the nonribosomal peptidyl transferases FemX, FemA and FemB. Inactivation of the femAB operon reduces the interpeptide to a monoglycine, leading to a poorly crosslinked peptidoglycan. femAB mutants show a reduced growth rate and are hypersusceptible to virtually all antibiotics, including methicillin, making FemAB a potential target to restore β-lactam susceptibility in methicillin-resistant S. aureus (MRSA). Cis-complementation with wild type femAB only restores synthesis of the pentaglycine interpeptide and methicillin resistance, but the growth rate remains low. This study characterizes the adaptations that ensured survival of the cells after femAB inactivation. Results: In addition to slow growth, the cis-complemented femAB mutant showed temperature sensitivity and a higher methicillin resistance than the wild type. Transcriptional profiling paired with reporter metabolite analysis revealed multiple changes in the global transcriptome. A number of transporters for sugars, glycerol, and glycine betaine, some of which could serve as osmoprotectants, were upregulated. Striking differences were found in the transcription of several genes involved in nitrogen metabolism and the arginine-deiminase pathway, an alternative for ATP production. In addition, microarray data indicated enhanced expression of virulence factors that correlated with premature expression of the global regulators sae, sarA, and agr. Conclusion: Survival under conditions preventing normal cell wall formation triggered complex adaptations that incurred a fitness cost, showing the remarkable flexibility of S. aureus to circumvent cell wall damage. Potential FemAB inhibitors would have to be used in combination with other antibiotics to prevent selection of resistant survivors.


Related Articles

  • The killer bug. Shnayerson, Michael // Fortune;9/30/2002, Vol. 146 Issue 6, p149 

    Reports on a mutation of the Staphylococcus aureus (S. aureus) that is resistant to penicillin, methicillin, and vancomycin. Infection of a Michigan woman with a vancomycin-resistant strain; Effects of unstoppable infections in hospitals; Transmission of germs in hospitals; Vaccine from Nabi...

  • Impact of the agr Quorum-Sensing System on Adherence to Polystyrene in Staphylococcus aureus. Cuong Vuong; Saenz, Henri L.; Gotz, Friedrich; Otto, Michael // Journal of Infectious Diseases;12/1/2000, Vol. 182 Issue 6 

    Biofilm formation by Staphylococcus aureus is a serious problem in nosocomial infections. There are great differences in the capacity of S. aureus to express biofilms, but the reasons are unknown. In all, 105 S. aureus strains were tested for a correlation between the agr quorum-sensing system...

  • Norway Stops Superbug.  // Current Science;4/16/2010, Vol. 95 Issue 15, p14 

    The article reports on the move of the Norwegian government to cut back on too much use of antibiotics for the treatment of Staphylococcus aureus infections (MRSA) among patients which have yielded into positive results and reduced the number of people infected by the bacteria.

  • Daptomycin pharmacodynamics against Staphylococcus aureus hemB mutants displaying the small colony variant phenotype. Begic, Damir; von Eiff, Christof; Tsuji, Brian T. // Journal of Antimicrobial Chemotherapy (JAC);May2009, Vol. 63 Issue 5, p977 

    : Objectives Staphylococcus aureus small colony variants (SCVs) are slow-growing morphological variants associated with persistent infections. While vancomycin activity has been shown to be attenuated against SCVs of S. aureus, few data exist regarding daptomycin. The objective was to evaluate...

  • Assessment of risk factors in the development of MRSA infection at Gülhane Military Medical Faculty Education Hospital and the role of antibiotic use on the development of MRSA infection. Gunal, E.; Besirbellioglu, B. A.; Ersoz, F.; Avci, I. Y.; Eyigun, C. P. // BMC Proceedings;Jan2011 Supplement 6, Vol. 5, pP14 

    An abstract of the article "Assessment of risk factors in the development of MRSA infection at Guelhane Military Medical Faculty Education Hospital and the role of antibiotic use on the development of MRSA infection," by E. Gunal, F. Ersoz and C. P. Eyigun is presented.

  • STREP COVERAGE WITH POTENTIAL MRSA?  // Clinical Advisor;Sep2009, Vol. 12 Issue 9, p34 

    The article presents an answer to a question on antibiotics that can be used to treat methicillin-resistant Staphylococcus aureus (MSRA).

  • Endemic linezolid-resistant Staphylococcus epidermidis in a critical care unit. Treviño, M.; Martínez-Lamas, L.; Romero-Jung, P. A.; Giráldez, J. M.; Alvarez-Escudero, J.; Regueiro, B. J. // European Journal of Clinical Microbiology & Infectious Diseases;May2009, Vol. 28 Issue 5, p527 

    The aim of this article was to report the emergence of patient infections with linezolid-resistant Staphylococcus epidermidis (LRSE) in a tertiary university hospital. Our objectives were to determine the molecular mechanism of the resistance, set up the genetic relationship among isolates, and...

  • Short-course therapy of catheter-related Staphylococcus aureus bacteremia: a meta-analysis. Jernigan, John A.; Farr, Barry M.; Jernigan, J A; Farr, B M // Annals of Internal Medicine;8/15/93, Vol. 119 Issue 4, p304 

    Objective: To determine, through structured methodologic review of published articles, the effectiveness of short-course (< or = 2 weeks) antibiotic therapy for catheter-related Staphylococcus aureus bacteremia.Data Sources: English-language publications on...

  • Failure of Clindamycin Treatment of Methicillin-Resistant Staphylococcus aureus Expressing Inducible Clindamycin Resistance In Vitro.  // Clinical Infectious Diseases;11/1/2003, Vol. 37 Issue 9, p1257 

    We report a case of a surgical site infection caused by clindamycin-susceptible, erythromycin-resistant methicillin-resistant Staphylococcus aureus (MRSA) that did not respond to treatment with clindamycin. The MRSA isolate obtained after treatment was resistant to clindamycin but was found to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics